CCM
PBYI icon

Cornerstone Capital Management’s Puma Biotechnology PBYI Stock Holding History

Cornerstone Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.73M Sell
25,724
-456,983
-95% -$23.1M 0.27% 41
2016
Q2 		$14.4M Sell
482,707
-126,492
-21% -$3.95M 0.76% 40
2016
Q1 		$17.9M Buy
609,199
+132,194
+28% +$5.97M 0.78% 40
2015
Q4 		$37.4M Sell
477,005
-18,140
-4% -$1.42M 1.53% 31
2015
Q3 		$37.3M Buy
495,145
+178,113
+56% +$16.8M 1.58% 28
2015
Q2 		$37M Buy
+317,032
New +$57.4M 1.21% 33

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Cornerstone Capital Management's PBYI Position: Q3 2016 in Review

Cornerstone Capital Management reduced its Puma Biotechnology (PBYI) stake by 95% in Q3 2016, selling an estimated $23.1M and leaving 25,724 shares worth $1.73M. The position accounts for 0.27% of the portfolio, ranked #41.

Cornerstone Capital Management first reported a position in PBYI in Q2 2015 and has held it in 6 quarters since. The position peaked at $37.4M in Q4 2015. 149 funds tracked by Wall St. Rank hold PBYI as of Q3 2016.

  • Cornerstone Capital Management held 25,724 shares of Puma Biotechnology worth $1.73M as of Q3 2016.
  • Cornerstone Capital Management sold 456,983 Puma Biotechnology shares in Q3 2016, an estimated $23.1M.
  • Puma Biotechnology made up 0.27% of Cornerstone Capital Management's portfolio in Q3 2016, its #41 holding.
  • Cornerstone Capital Management first reported a position in Puma Biotechnology in Q2 2015 and has held it in 6 quarters since.
  • Cornerstone Capital Management's Puma Biotechnology position peaked at $37.4M in Q4 2015.
  • 149 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2016.

Based on Cornerstone Capital Management's 13F filing for Q3 2016, filed 3 Nov 2016.